Enabling Concierge Physicians to Go Beyond Their Reach
Two million Americans are being diagnosed with cancer every year. Six hundred thousand die from cancer annually. When your patients are diagnosed with cancer they expect to get the best treatment from the best source. Yet no two cancers are alike and no two patients are alike.
No two cancers are exactly alike
and each may require a different treatment
Cancer research advances every day
new drugs, new treatments and new clinical trials
2/3 of diagnoses change after 2nd opinion
as data and treatment options are not readily accessible to everyone
Staying within the boundaries of what is known and included in your local standard care, may not be in the best interest of your patient.
So much data but how do you ensure your patients navigate their treatment plan effectively? Who is the best expert in their specific case? What is right for them?
N1X10 Empowers Concierge Physicians
At N1X10 we will work with you, to review each unique case and provide guidance and support from the initial diagnosis and throughout the various treatment phases. Since we are not confined by specific caregiver or institutional constraints, we can provide information about a broad set of trials and treatments beyond geographic boundaries and standard protocols. Collaboration with you, the caregiver, ensures we deliver precision care that considers not just the specific tumor, but the overall patient needs – behavioral, emotional, socioeconomic.
Our Unique Value For Concierge Physicians
What do our POA services include?
diagnostic gaps and validate diagnosis
treatment options globally
guide and close knowledge gaps
collaborative decision making
with adverse effects and wellbeing
ahead for all possibilities
Our Proprietary Technology
To optimize our service and democratize personalized oncology advocacy to as many cancer patients as possible, we have developed cutting-edge, proprietary technologies that enable us to continuously improve on N1X10’s effectiveness, accessibility, and affordability.
The N1X10 Advocacy Team uses a proprietary and innovative dashboard complemented with a smartphone patient app, both designed to deliver personalized oncology advocacy and tailored patient education.
What Our Physicians Say
Dr. Jonathan Schmidt, 2023
What Sets Us Apart
Up to date, tailored treatment
Accounting for all of your specific needs
Proven Track Record
Assisting cancer patients for years
Guiding you every step of the way
Centralized facilitating platform
Frequently Asked Questions
The purpose of our service is to minimize your patient’s regret factor. N1X10 has a global network of evidence-based experts in all areas of cancer care from diagnosis to treatment to supportive care.
Patients are assigned a personalized advocacy team that will identify the best experts for their needs and preferences. This can include, for example, identifying a pathologist to confirm the cancer diagnosis or an expert in the treatment approach that was recommended. The advocacy team will assist in contacting the expert and work in conjunction with them. In addition, the advocacy team will help your patient understand the expert’s opinion. The advocacy team will make sure that no stone is left unturned.
Our lead advocates are certified oncologists with extensive experience, from leading cancer centers, in the US and Canada. In addition to being board certified oncologists, our physicians function as a trusted advocate for your patients, assisting them in navigating their cancer journey more successfully. The lead advocate may not be specialized in a patient’s unique cancer diagnosis; however, they can identify the best experts using our broad global network. There are no geographic or institutional limits to our network.
We have developed a worldwide network of experts with whom we have cultivated close working relationships. In our advocacy work, we prioritize identifying the key opinion leaders in their respective fields.
In general, referrals to medical professionals should be provided by the patient’s PCP or treating oncologist. We will provide contact details and make an introduction when needed.
When it is warranted, we will connect the patient with the best experts for consultation or second opinions.
For those enrolled in the POA Premium plan, we will assist in contacting the experts and coordinating the meeting.
The research is currently being led by our lead oncology advocates (oncologists) using best practice of research. This is being validated through discussions with leading experts within the N1X10 network. N1X10 is planning to develop a dedicated research platform for N of one advocacy that will cross the boundaries of medical literature and include social networks, forums, and other resources.
We will collect all the clinical data, organize it, and review it to have a full understanding of the patient’s clinical condition. We will keep the clinical data up-to-date and collect any new data during the service period. Patients are more than welcome to share whatever data they have as they receive it. This can sometimes expedite the data collection process. The patient will also have access to their data via the N1X10 mobile app. In addition, with proper consent from the patient, the referring physician will be able to access the data on our HIPAA-compliant clinical platform.
We believe in transparency and in cooperation. It is important that the PCP and treating oncologist are aware of what we are doing together. With the patient’s permission, we will send regular updates to the PCP. The decisions that the patient makes will ultimately have to be in sync with the treating oncologist. We will help the patient prepare for discussions with the treating oncologist and we will be happy to furnish the patient with a summary that they can share. In addition, we are always open to having direct discussions with the treating oncologist and any other care professional as requested.
The service starts with a 3-month Planning & Intervention phase. Depending on the patient’s condition, this phase can be extended to address the patient’s unique needs. The next phase is the 9-month Surveillance phase. The patient will proceed to this phase after discussing it with their advocacy team and determining that it is the right decision for him or her. During the Surveillance phase the advocacy team continues to support the patient and, if needed, will discuss the option to resume an additional Planning & Intervention phase.